PATENT CLAIM ANALYSIS

Application Number: 16410037
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "211100"]

Abstract:
The present invention encompasses compounds of the formula (I) wherein the groups A and B are defined herein, which are suitable for the treatment of diseases related to Vanin, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.

Claim (Index 17):
A method of treating a patient suffering from Crohn's disease, ulcerative colitis, atopic dermatitis, systemic sclerosis, Non-Alcoholic Steatohepathitis (NASH), psoriasis, chronic kidney disease, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, rheumatoid arthritis, scleroderma, asthma, allergic rhinitis, allergic eczema, juvenile rheumatoid arthritis, juvenile idiopathic arthritis, graft versus host disease, psoriatic arthritis, colorectal cancer or pancreatic cancer related new onset diabetes, comprising administering to the patient a compound a therapeutically effective amount of a compound according to  claim 1 .

Metadata:
- Claim Count in Document: 38.0
- Percentile: 100.0
- Lexical Diversity: 1.36842
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16003252', '14772290', '14772295', '14772589', '14592480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7059338803297361
- 35 USC 102 Novelty (BERT): 0.5039812628782131
- Combined Prediction Score: 0.685738618584584
- Mean Citation Score: 196.481326
- Max Citation Score: 283.34122
- Similarity Product: 256.3883302427292

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test